Retatrutide 30mg

Retatrutide — 30mg | Purity ≥99%

Retatrutide is a novel triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. As one of the most advanced peptides currently under investigation, it has generated substantial interest in metabolic and cardiometabolic research for its multi-receptor activity profile.

Key Research Areas:

• Triple incretin receptor agonism (GLP-1, GIP, glucagon)
• Metabolic regulation and energy homeostasis
• Cardiometabolic and hepatic function studies
• Adipose tissue biology and lipid metabolism

Specifications:

• Quantity: 30mg
• Purity: ≥99% (HPLC verified)
• Form: Lyophilised powder
• Storage: Store at -20°C, away from light and moisture

For research use only. Not for human consumption. This product is intended solely for in vitro and laboratory research purposes.